Abbott Stock Surges 6%: How Diagnostics Growth Drives 2026 Profit Guidance Raise and Investor Sentiment
Abbott Laboratories (ABT) shares surged over 6% after Q2 2026 earnings beat, driven by diagnostics revenue up 11% to $4.2 billion. Management raised full-year profit...
